The complexity and diversity of cell and gene therapies and treatments still restrains the industry’s ability to identify and deliver the proper treatment and a positive patient experience. In 2023, I expect we will see a considerable increase in critical data gathering and machine learning analysis that will lead to substantive improvements. This use of…

Cell and gene therapies promise to enable broad changes in the healthcare system over the next decade, prompting a growing number of cell and gene therapy companies to join the space. Consider that a cell therapy technique could eliminate the need for immunosuppressive drugs for some organ transplant patients. Cell and gene therapy companies also…

Mission Bio (San Francisco) is a growth-stage company spun out of the microfluidics lab at the University of California San Francisco (UCSF) in 2014. “We have been commercial since late 2017,” said the company’s CEO, Yan Zhang, in a recent interview. Initially focusing on oncology, Mission Bio has cast its gaze across precision medicine to…

By Trevor Smith, MS MBA, Product Manager, Immune Cells Human AB Serum is a staple in the biological research field, providing nutrients, vitamins and necessary growth factors in cellular culture and reliable controls in in vitro diagnostics. To truly understand serum, it is important to learn about its different production and processing methods. Starting material…